Delivery Order SPE2DE21D0007-SPE2D625F3C4Q
Award Date
4/17/25
Potential Completion Date
5/7/25
Potential Value
$2.9K
Federal Agency
Medical Supply Chain
Awardee
Ortho-Clinical Diagnostics, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $4,985.58 firm fixed-price delivery order contract awarded by the Medical Supply Chain division of the Defense agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for the provision of "BLOOD GROUP SERUM" and does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture registered in SAM.gov and specializes in supplying sophisticated medical...
This is a $1,849.78 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Defense Health Agency (DHA). The contract is for the provision of 4567880985 ! BLOOD GROUPING SERUM, with a period of performance ending on May 1, 2025. Ortho-Clinical Diagnostics is a self-certified HUBZone joint venture and a manufacturer of goods, primarily supplying critical medical diagnostic equipment and associated reagents to various federal...
This is a $4,418.30 fixed-price delivery order awarded to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, by the Defense Health Agency for blood group serum supplies. The order has a period of performance ending on November 29, 2024. Ortho-Clinical Diagnostics is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to federal agencies including the Department of Veterans Affairs and...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $1,524.24, is for the delivery of 4563969866 SERUM ANTI D 10ML 3S. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and has an ultimate completion date of April 3, 2024. The contract does not have a set-aside designation. Ortho-Clinical...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of anti-A bioclone 15x10ml. The contract was awarded by the Medical Supply Chain, a component of the Defense agency, and has a ceiling value of $1,832.54. The contract is a Delivery Order with a fixed price and economic price adjustment pricing type, and has an ultimate completion date of April 28, 2025. The contract does not have a set-aside designation, indicating...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer and self-certified HUBZone joint venture, by the Medical Supply Chain division of the Defense agency. The $5,299.18 fixed-price delivery order contract is for the supply of 4,568,054,958 units of "ANTI-DST 15X10ML" medical products, with a completion date of May 12, 2025. The contract was awarded on April 28, 2025 and does not utilize any set-aside designations,...
This is a $849,897.70 firm fixed-price purchase order contract awarded by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The contract is for blood bank testing supplies and services, with a period of performance ending on September 30, 2028. The contract does not have a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has been awarded multiple Indefinite...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the delivery of ANTI-M 1X5ML medical supplies. The $1,657.70 fixed-price contract with economic price adjustment was awarded by the Medical Supply Chain agency, which is an alternate name for the Defense agency. The contract is a delivery order with a completion date of May 19, 2025 and does not utilize any set-aside designations, indicating open competition. Ortho-Clinical...
This is a delivery order award to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the provision of blood grouping serum. The $5,287.00 fixed-price with economic price adjustment contract has a completion date of November 29, 2024 and was awarded on November 7, 2021 by the Defense Logistics Agency Troop Support Medical, which is part of the Department of Defense. No set-aside designation was used for this award. Ortho-Clinical Diagnostics is a manufacturer of a...